DCM
TWST icon

Deuterium Capital Management’s Twist Bioscience TWST Stock Holding History

Deuterium Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,000
Closed -$225K – 74
2022
Q3 		$225K Buy
+4,000
New +$170K 0.94% 20

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Deuterium Capital Management's TWST Position: Q4 2022 in Review

Deuterium Capital Management sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 4,000 shares — an estimated $225K sold.

Deuterium Capital Management first reported a position in TWST in Q3 2022 and held it in 1 quarter. The position peaked at $225K in Q3 2022. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Deuterium Capital Management reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Deuterium Capital Management sold 4,000 Twist Bioscience shares in Q4 2022, an estimated $225K.
  • Deuterium Capital Management first reported a position in Twist Bioscience in Q3 2022 and held it in 1 quarter.
  • Deuterium Capital Management's Twist Bioscience position peaked at $225K in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Deuterium Capital Management's 13F filing for Q4 2022, filed 3 Feb 2023.